Session videos

session2_thumbnail

Session: Non-adherence is the new cardiovascular risk factor

Cardiovascular diseases are often asymptomatic. Their “silence” is one of the contributing factors to treatment non-adherence. Based on an extensive literature review, Professor Lale Tokgözoğlu demonstrates the medical and social burden of treatment non-adherence in patients with cardiovascular diseases. Her presentation addresses the causes of non-adherence as declared by patients and non-adherence’s consequences for their…

session1_thumbnail

Session: Welcome and congress introduction

Professor John Weinman and Dr. Matthias Mueller open the congress by introducing the challenges adherence poses to global health and highlighting the innovative potential that dialogue between behavioral science and clinical practice offers. Speakers Prof. John Weinman Dr. Matthias Mueller

Session: Acting on the unseen: How do we help patients to remain adherent when they are asymptomatic?

Treatment non-adherence in patients can be associated with lack of symptoms, interference with daily schedule, lack of understanding of disease or treatment, or fear of stigma associated with disease1.  This is especially the case with conditions like hypertension where many patients can be asymptomatic. However, medication non-adherence is not without consequences and can increase a…

Session: Principles of Anti-Microbial Resistance (AMR) stewardship and impact of adherence

With antimicrobials, non-adherence affects more than the individual patient1—it also drives treatment-resistant pathogens2. To keep antimicrobials alive, physicians must help their patients adhere to their medication, said Prof. Giamarellos-Bourboulis, who examined the barriers to antibiotic use and adherence and how to overcome them. To improve adherence, physicians must continue their education on the topic and leverage…

Session: The paradox of non-adherence in symptomatic disease

Though it’s easy to grasp why asymptomatic patients may be non-adherent, healthcare providers may be perplexed by non-adherence in patients who suffer from unpleasant symptoms. A 2021 study found that 45% of such patients were taking insufficient doses of their treatment despite experiencing symptoms ranging from irritating to incapacitating. “Adherence often goes unrecognized. We think…

Session: Behaviors and beliefs: the foundations of adherence

Adherence can vary between patients or within the same patient over time and across treatments1. Prof. Rob Horne emphasized that non-adherence is a variable behavior, not a trait cemented into a patient’s personality. Horne commented: “We assume if we inform the patient and if they have the correct knowledge, then action will follow, but 50%…